Pascal Edrich

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

Elinor Ben‐Menachem, Pascal Edrich, Betty Van Vleymen et al. · Epilepsy Research · 2003 · 79 citations

Sustained Efficacy, Medicine, Psychotropic Medication +5

Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study

Jing‐Jane Tsai, Der‐Jen Yen, Mo‐Song Hsih et al. · Epilepsia · 2006 · 72 citations

Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies

William E. Rosenfeld, Selim R. Benbadis, Pascal Edrich et al. · Epilepsy Research · 2009 · 56 citations

Psychotropic Medication, Pediatrics, Placebo-controlled Studies +7

Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd beyond one year.

Richard A. Larson, Phillipp D. Le Coutre, Josy Reiffers et al. · Journal of Clinical Oncology · 2010 · 38 citations

Pharmacotherapy, Myeloid Neoplasia, Chronic Phase +16

Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study

Patrick Kwan, Shih Hui Lim, Yotin Chinvarun et al. · Epilepsy & Behavior · 2010 · 22 citations

Adjunctive Therapy, Uncontrolled Partial Epilepsy, Psychiatry +8